Swelling: FDA reporting patterns
92,152 FDA FAERS reports mention Swelling. 56,648 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 13,085 reports
- Adalimumab: 12,694 reports
- Methotrexate: 11,136 reports
- Tocilizumab: 9,884 reports
- Abatacept: 9,615 reports
- Leflunomide: 9,356 reports
- Rituximab: 9,141 reports
- Infliximab: 8,533 reports
- Prednisone: 8,464 reports
- Hydroxychloroquine: 8,369 reports
- Certolizumab Pegol: 8,136 reports
- Golimumab: 8,020 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.